POWERWAND Midline IV Catheter Achieves 23,000 Catheter Days with Zero Bloodstream Infections

Tuesday, October 24, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

SAN DIEGO, Oct. 24, 2017 /PRNewswire/ -- Access Scientific announced today that the POWERWAND™ midline catheter now has over 23,000 catheter days of scientific

data without a single catheter-related bloodstream infection (CRBSI).  This follows new data presented at the prestigious Association for Vascular Access national conference, which took place in Phoenix, AZ in late September.

Data collected at Methodist Hospitals in Indiana,  representing 2,688 patient days of POWERWAND use, indicated the use of POWERWAND lead to a 35% reduction in the number of peripherally inserted central catheters (PICCs) placed.  Zero bloodstream infections were reported during the 12-month study period and 79% of patients utilized POWERWAND through their completion of therapy.

Methodist Hospitals' data, coupled with five peer-reviewed, published studies and seven scientific posters demonstrate POWERWAND's consistently superior performance.  In addition to the zero CRBSI achievement, the accumulated studies & posters prove POWERWAND's superior blood drawability and lowest total complication rate and highest completion of therapy rate of any midline ever studied.

POWERWAND is made of a unique catheter material (ChronoFlex C®) that, when coupled with Access Scientific's proprietary manufacturing processes, produces a catheter capable of outperforming the competition. 

"The consistently superior clinical performance of the POWERWAND is extraordinary," remarked Steve Bierman, Access Scientific's Founder and Chief Medical Officer. "POWERWAND's proprietary catheter material and manufacturing processes are unparalleled.  POWERWAND is the evidence-based midline of choice."

About Access Scientific, LLC

Access Scientific, LLC, based in San Diego, CA, is an evidence-based, infection prevention company offering innovative vascular access devices designed to reduce the need for and risk of vascular device-related complications, including bloodstream infections. See www.accessscientific.com for full product offering and clinical studies.

Contact:  Liz Dowling, (415) 388-2794Dowling & Dennis Public RelationsEmail: [email protected] 

 

View original content:http://www.prnewswire.com/news-releases/powerwand-midline-iv-catheter-achieves-23000-catheter-days-with-zero-bloodstream-infections-300541735.html

SOURCE Access Scientific, LLC



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store